227 related articles for article (PubMed ID: 11514635)
1. Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.
van Kerkhof P; Alves dos Santos CM; Sachse M; Klumperman J; Bu G; Strous GJ
Mol Biol Cell; 2001 Aug; 12(8):2556-66. PubMed ID: 11514635
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand.
van Kerkhof P; Strous GJ
Biochem Soc Trans; 2001 Aug; 29(Pt 4):488-93. PubMed ID: 11498015
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.
Rocca A; Lamaze C; Subtil A; Dautry-Varsat A
Mol Biol Cell; 2001 May; 12(5):1293-301. PubMed ID: 11359922
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-proteasome pathway and the regulation of growth hormone receptor availability.
Strous GJ; van Kerkhof P
Mol Cell Endocrinol; 2002 Nov; 197(1-2):143-51. PubMed ID: 12431807
[TBL] [Abstract][Full Text] [Related]
6. Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.
Melman L; Geuze HJ; Li Y; McCormick LM; Van Kerkhof P; Strous GJ; Schwartz AL; Bu G
Mol Biol Cell; 2002 Sep; 13(9):3325-35. PubMed ID: 12221136
[TBL] [Abstract][Full Text] [Related]
7. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor.
Vecchione A; Marchese A; Henry P; Rotin D; Morrione A
Mol Cell Biol; 2003 May; 23(9):3363-72. PubMed ID: 12697834
[TBL] [Abstract][Full Text] [Related]
8. The proteasome regulates receptor-mediated endocytosis of interleukin-2.
Yu A; Malek TR
J Biol Chem; 2001 Jan; 276(1):381-5. PubMed ID: 11032838
[TBL] [Abstract][Full Text] [Related]
9. Role of proteasomes in the degradation of short-lived proteins in human fibroblasts under various growth conditions.
Fuertes G; Villarroya A; Knecht E
Int J Biochem Cell Biol; 2003 May; 35(5):651-64. PubMed ID: 12672457
[TBL] [Abstract][Full Text] [Related]
10. Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure.
Moulin S; Bouzinba-Segard H; Kelly PA; Finidori J
Cell Signal; 2003 Jan; 15(1):47-55. PubMed ID: 12401519
[TBL] [Abstract][Full Text] [Related]
11. Insulin inhibition of proteasome activity in intact cells.
Hamel FG; Bennett RG; Harmon KS; Duckworth WC
Biochem Biophys Res Commun; 1997 May; 234(3):671-4. PubMed ID: 9175773
[TBL] [Abstract][Full Text] [Related]
12. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
13. Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor.
Govers R; van Kerkhof P; Schwartz AL; Strous GJ
EMBO J; 1997 Aug; 16(16):4851-8. PubMed ID: 9305627
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
[No Abstract] [Full Text] [Related]
16. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
[TBL] [Abstract][Full Text] [Related]
17. Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions.
Fuertes G; Martín De Llano JJ; Villarroya A; Rivett AJ; Knecht E
Biochem J; 2003 Oct; 375(Pt 1):75-86. PubMed ID: 12841850
[TBL] [Abstract][Full Text] [Related]
18. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators.
Yan F; Gao X; Lonard DM; Nawaz Z
Mol Endocrinol; 2003 Jul; 17(7):1315-31. PubMed ID: 12663742
[TBL] [Abstract][Full Text] [Related]
19. Degradation of methoxysuccinyl-phe-leu-phe-7-amido-4-trifluoromethyl coumarin (FLF) in cultured myotubes and HepG2 cells is proteasome- and calpain/calcium-dependent.
Li BG; Fang CH; Hasselgren P
Int J Biochem Cell Biol; 2000 Jun; 32(6):677-86. PubMed ID: 10785364
[TBL] [Abstract][Full Text] [Related]
20. Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function.
Strous GJ; Gent J
FEBS Lett; 2002 Oct; 529(1):102-9. PubMed ID: 12354620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
